Lucy Lu
2017 - AVENUE THERAPEUTICS
In 2017, Lucy Lu earned a total compensation of $2M as Chief Executive Officer at AVENUE THERAPEUTICS, a 490% increase compared to previous year.
Compensation breakdown
| Bonus | $282,625 |
|---|---|
| Salary | $294,940 |
| Stock Awards | $1,455,550 |
| Total | $2,033,115 |
Lu received $1.5M in stock awards, accounting for 72% of the total pay in 2017.
Lu also received $282.6K in bonus and $294.9K in salary.
Rankings
In 2017, Lucy Lu's compensation ranked 5,416th out of 14,666 executives tracked by ExecPay. In other words, Lu earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,416 out of 14,666 | 63rd |
Division Manufacturing | 1,943 out of 5,772 | 66th |
Major group Chemicals And Allied Products | 582 out of 2,075 | 72nd |
Industry group Drugs | 447 out of 1,731 | 74th |
Industry Pharmaceutical Preparations | 352 out of 1,333 | 74th |
Source: SEC filing on April 30, 2018.
Lu's colleagues
We found two more compensation records of executives who worked with Lucy Lu at AVENUE THERAPEUTICS in 2017.
News
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019